A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Metformin in Combination With Secukinumab for the Treatment of Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients
Latest Information Update: 27 Mar 2026
At a glance
- Drugs Metformin (Primary) ; Secukinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
Most Recent Events
- 23 Mar 2026 New trial record